Search details
1.
MATTERHORN: phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer.
Future Oncol
; 18(20): 2465-2473, 2022 Jun.
Article
in English
| MEDLINE | ID: mdl-35535555
2.
CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III, randomized, double-blind, multicenter study.
Int J Gynecol Cancer
; 30(7): 1065-1070, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32447296
3.
FDA Approval Summary: Selpercatinib for the Treatment of Advanced RET Fusion-Positive Solid Tumors.
Clin Cancer Res
; 29(18): 3573-3578, 2023 09 15.
Article
in English
| MEDLINE | ID: mdl-37265412
4.
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma.
NEJM Evid
; 1(8): EVIDoa2100070, 2022 Aug.
Article
in English
| MEDLINE | ID: mdl-38319892
Results
1 -
4
de 4
1
Next >
>>